The results indicated that Shenfu injection has a potential therapeutic effect on IPF, and its curative effect may be exerted through anti-inflammation and anti-cell apoptosis, involving pathways in tuberculosis, hepatitis B, apoptosis and IL-17 signaling. This evidence concerns the gene IL17A and idiopathic pulmonary fibrosis.